Pharmafile Logo
Pharmafocus logo
Advanced Search

Daiichi Sankyo

Showing 15 posts of 59 posts found.

Daiichi Sankyo

Daiichi sheds more US jobs as generic losses take their toll

October 20, 2015
Daiichi, Daiichi Sankyo, generic competition, generics, job losses, patent cliff, patents, redundancies

The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …

News
Daiichi Sankyo

NICE recommends Daiichi’s Lixiana for blood clots

July 13, 2015
Sales and Marketing DVT, Daiichi, Daiichi Sankyo, Lixiana, NICE, NOACs, VTE, anticoagulant, blood clots, edoxaban, novel anticoagulant. PE

Daiichi Sankyo has won a speedy approval from NICE, after the NHS guidance body approved its newly-launched blood clotting drug …

News
Daiichi image

Daiichi Sankyo launches clotting drug Lixiana in UK

July 10, 2015
Medical Communications, Sales and Marketing Daiichi Sankyo, Lixiana, NOAC, VTE, anticoagulant, atrial fibrillation, blood clots, edoxaban, novel anticoagulant, strokes, warfarin

Daiichi Sankyo’s Lixiana has become the latest pharma offering in the class of newer oral anticoagulants in the UK.Lixiana (edoxaban) …

News
Merck image

Merck to test Keytruda combinations

May 8, 2015
Sales and Marketing BMS, Daiichi Sankyo, Merck, Plexxikon, keytruda, pembrolizumab

Merck will be teaming up with Daiichi Sankyo’s subsidiary Plexxikon to investigate immunotherapy combinations in cancer. A collaborative clinical trial …

News
Daiichi image

Daiichi Sankyo to sell Sun Pharma stake

April 21, 2015
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, India, Ranbaxy, Sun Pharma, generics

Daiichi Sankyo is to sell off all or part of its stake in Sun Pharma and back away from the …

News
Daiichi image

Daiichi Sankyo cuts 16% of US staff

March 27, 2015
Sales and Marketing Benicar, Daiichi Sankyo, FDA, Ranbaxy, Welchol, ambit, colesevelam, cuts, olmesartan

Daiichi Sankyo is laying off 16% of its staff at its US commercial headquarters as the company braces itself for …

News
Sun Pharmaceutical Industries, India

Sun Pharma completes Ranbaxy acquisition

March 26, 2015
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, India, Ranbaxy, Sun Pharma, cci

Sun Pharma has closed its mega merger deal with Ranbaxy and begun the integration of the two businesses. The combined …

News
Daiichi image

Daiichi-Sankyo pays $39m to settle allegations

January 12, 2015
Sales and Marketing Azor, Benicar, Daiichi Sankyo, Daiichi-Sankyo, Tribenzor, Welchol, kickbacks, us justice

Daiichi-Sankyo will pay the US government and state Medicaid programmes $39 million to resolve claims that it violated the False …

News
Daiichi image

Daiichi-Sankyo blood drug gets FDA nod

January 12, 2015
Sales and Marketing BMS, Daiichi Sankyo, Daiichi-Sankyo, FDA, Pfizer, Pradaxa, atrial fibrillation, blood, savaysa

The US Food and Drug Administration has shown Daiichi-Sankyo’s anti-clotting drug Savaysa the green light to reduce the risk of …

News
Daiichi Sankyo image

Daiichi Sankyo pays $410m for Ambit Biosciences

September 29, 2014
Sales and Marketing AML, Daiichi Sankyo, ambit biosciences, quizartinib

Daiichi Sankyo has bought San Diego-based Ambit Biosciences in a deal aimed at shoring up the Japanese company’s cancer research. …

News
Ranbaxy image

Ranbaxy hit with second generic Lipitor recall

March 10, 2014
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, Ranbaxy, hamburg, manufacturing

India’s largest native generic drugmaker Ranbaxy has come under greater pressure this week after the US has again sent out …

News
glenn_gormley

Daiichi Sankyo hires two new executives

October 7, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daiichi Sankyo

Daiichi Sankyo has appointed Glenn Gormley to be its corporate president and chairman, and Greg Barrett as a new acting …

Appointment
iphone_4

AZ/Daiichi Sankyo create Japan iPhone app for acid reflux

September 19, 2013
Medical Communications, Sales and Marketing AstraZeneca, Daiichi Sankyo, Japan, Nexium, app, iphone

News
Daiichi Sankyo image

Edoxaban ‘as effective as warfarin’

September 2, 2013
Sales and Marketing DVT, Daiichi Sankyo, VTE, warfarin

Daiichi Sankyo is celebrating after its once-a-day blood thinner edoxaban proved as effective as warfarin in a late-stage trial, although …

News

Glass particles force recall of Ranbaxy Lipitor

November 27, 2012
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, Lipitor, Pfizer, Ranbaxy, recall

Ranbaxy Pharmaceuticals is recalling around 40 batches of its generic atorvastatin tablets after discovering that some of the product may …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025